LOMEDEUCITINIB

UNII:	EYQ7KA55XA
Type:	INGREDIENT SUBSTANCE
Formula:	C₁₈H₂₀N₆O₄S
Preferred Substance Name:	LOMEDEUCITINIB
InChIKey:	VWIVBQZLVAGLMH-ASGODXDTSA-N
GSRS Full Record:	EYQ7KA55XA i

2328068-29-5
3-Pyridazinecarboxamide, N-(methyl-d3)-4-[[3-(methylsulfonyl)-2-pyridinyl]amino]-6-[[(1R)-spiro[2.2]pent-1-ylcarbonyl]amino]-
4-[(3-methylsulfonyl-2-pyridinyl)amino]-6-[[(2R)-spiro[2.2]pentane-2-carbonyl]amino]-N-(trideuteriomethyl)pyridazine-3-carboxamide
BMS 986322 [WHO-DD]
BMS-986322
BMS-986322-01
LOMEDEUCITINIB [USAN]
Lomedeucitinib
N-[(<sup>2</sup>H<sub>3</sub>)methyl]-4-{[3-(methanesulfonyl)pyridin-2-yl]amino}-6-(spiro[2.2]pentan-1-carboxamido)pyridazine-3-carboxamide
lomedeucitinib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LOMEDEUCITINIB

Synonyms and Mappings

Resources